Variants of human papillomavirus types 16 and 18: Histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear

International Journal of Gynecological Pathology

Volumn 25, Issue 4, 2006, Pages 393-397

  Rabelo Santos, Silvia Helena ^a   Villa, Luísa Lina ^b   Derchain, Sophie Françoise ^c   Ferreira, Silvaneide ^b   Sarian, Luis Otávio Zanatta ^c   Ângelo Andrade, Liliana Aparecida Lucci ^c   Do Amaral Westin, Maria Cristina ^c   Zeferino, Luiz Carlos ^c,d  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d NONE   (Brazil)

Author keywords

Adenocarcinoma; Cervical neoplasia; Human papillomavirus; Type 16; Type 18; Variants

Indexed keywords

ADULT; ARTICLE; CANCER CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; VAGINAL SMEARS; VARIATION (GENETICS);

EID: 33750477024     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000215302.17029.0c     Document Type: Article

References (29)

1. Ronnet BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance: cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
2. Levine L, Lucci JA, Dinh TV. Atypical glandular cells: new Bethesda Terminology and Management Guidelines. Obstet Gynecol Surv 2003;58:399-406.
3. Derchain SF, Rabelo-Santos SH, Sarian LO, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:618-23.
4. Krane JF, Lee KR, Sun D, et al. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004;121:87-92.
5. Chhieng Dc, Gallaspy S, Yang H, et al. Women with atypical glandular cells: a long-term follow-up study in a high-risk population. Am J Clin Pathol 2004;122:575-9.
6. Pirog EC, Kleter B, Olgac S, et al. Prevalence of HPV-DNA in different histologic subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-62.
7. Andersson A, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical carcinogenesis. Eur J Cancer 2001;37:246-50.
8. Altekruse SF, Lacey JV, Brinton LA, et al. Comparison of HPV genotypes, sexual, and reproductive risk factors of cervical adenocarcinomas and squamous cell carcinoma, northeastern United States. Am J Obstet Gynecol 2003;188:657-63.
9. Andersson S, Mints M, Sallstrom J, et al. The relative distribution of oncogenic types of human papillomavirus in benign, premalignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev 2005;29:37-41.
10. Burk RD, Masanori T, Gravitt PE, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003;63:7215-20.
11. De Boer MA, Peters LA, Aziz MF, et al. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 2004;94:488-94.
12. Tornesello ML, Duraturo ML, Salatiello I, et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 2004;74:117-26.
13. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;5,93:1325-30.
14. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72.
15. Seedorf K, Krammer G, Durst M, et al. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5.
16. Ong CK, Chan SY, Campo MS, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 1993;67:6424-31.
17. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81:2959-68.
18. Cruz MR, Cerqueira DM, Cruz WB, et al. Prevalence of human papillomavirus type 16 variants in the Federal District, Central Brazil. Mem Inst Oswaldo Cruz 2004;99:281-2.
19. Gravitt PE, Peyton RJ, Apple RJ, et al. Genotyping of papillomavirus by using L1 consensus PCR products by a single-hybridization reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
20. Gravitt PE, Peyton RJ, Apple RJ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
21. Franco EL, Villa LL, Rahal P, et al. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst 1994;19,86:1558-9.
22. Villa LL, Rahal P, Franco EL. Molecular variant analysis as a tool in natural history studies of human papillomavirus infection an d cervical neoplasia. In: Franco EL, Monsonego J eds. Developments in Cervical Cancer Screening and Prevention. Oxford: Blackwell Science, 1997:379-85.
23. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumors. In: World Health Organization-International Histological Classification of Tumors, 2nd ed. Berlin: Springer-Verlag, 1994:36-49.
24. Lizano M, Berumen J, Guido M, et al. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 1997;89:1227-31.
25. De Boer MA, Peters LA, Aziz MF, et al. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 2005;10,114:422-5.
26. Madeleine MM, Daling JR, Schwartz SM, et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001;10:171-7.
27. DeMay RM. The Pap smear. In: The Art and The Science of Cytopathology. Chicago: ASCP Press, 1993:61-185.
28. Walboomers JM, Jacobs MV, Bosch FX, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
29. Martens JE, Arends J, Van Der Linden PJQ, et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical steam cell. Anticancer Res 2004;24:771-6.